@article{66239f8b7c3547bcbfc1a9e343f2548c,
title = "PCSK9 Inhibitors Prior Authorization: Redundant Process Due for a Redesign",
keywords = "Editorials, cholesterol, cost-benefit analysis, drug costs, patient care",
author = "Khurram Nasir and Suveen Angraal and Virani, {Salim S.}",
note = "Funding Information: Dr Virani reports receiving grant support from Department of Veterans Affairs, World Heart Federation, and Honorarium from the American College of Cardiology (Associate Editor for Innovations, www.acc.org). The other authors report no conflicts.",
year = "2019",
month = aug,
day = "1",
doi = "10.1161/CIRCOUTCOMES.119.005910",
language = "English (US)",
volume = "12",
journal = "Circulation: Cardiovascular Quality and Outcomes",
issn = "1941-7713",
publisher = "Lippincott Williams and Wilkins",
number = "8",
}